These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 20151775)

  • 1. The broken pen penalty.
    Lakshmanadoss U; Ayyappan S; Jain A; Konezny M; Rajamani K
    Diabetes Technol Ther; 2010 Mar; 12(3):241-3. PubMed ID: 20151775
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Severe deterioration of metabolic control caused by malfunction of a disposable insulin pen device.
    Boronat M; García-Delgado Y; Pérez-Martín N; Nóvoa FJ
    J Am Board Fam Med; 2008; 21(6):575-6. PubMed ID: 18988726
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Optimizing glycemic control with insulin glargine.
    Williams JB
    Diabetes Technol Ther; 2003; 5(3):471-3. PubMed ID: 12828834
    [No Abstract]   [Full Text] [Related]  

  • 4. Ease of use and patient preference injection simulation study comparing two prefilled insulin pens.
    Clark PE; Valentine V; Bodie JN; Sarwat S
    Curr Med Res Opin; 2010 Jul; 26(7):1745-53. PubMed ID: 20482243
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adherence to premixed insulin in a prefilled pen compared with a vial/syringe in people with diabetes in Singapore.
    Cheen HH; Lim SH; Huang MC; Bee YM; Wee HL
    Clin Ther; 2014 Jul; 36(7):1043-53. PubMed ID: 24913030
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Humalog(®) KwikPen™: an insulin-injecting pen designed for ease of use.
    Schwartz SL; Ignaut DA; Bodie JN
    Expert Rev Med Devices; 2010 Nov; 7(6):735-43. PubMed ID: 21050084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Desensitization of allergy to human insulin and its analogs by administering insulin aspart and insulin glargine.
    Wu P; Ji C; Wang M; Zou S; Ge W
    Ann Endocrinol (Paris); 2013 Feb; 74(1):56-8. PubMed ID: 23351561
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Validation of the SoloSTAR insulin pen.
    Schwartz S; Vlajnic A
    Diabetes Technol Ther; 2008 Oct; 10(5):351-7. PubMed ID: 18715210
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comment on "The broken pen penalty" (Lakshmanadoss et al.).
    Moses AC
    Diabetes Technol Ther; 2010 Nov; 12(11):929-30. PubMed ID: 20879961
    [No Abstract]   [Full Text] [Related]  

  • 10. Predictors of initiating rapid-acting insulin analog using vial/syringe, prefilled pen, and reusable pen devices in patients with type 2 diabetes.
    Lee LJ; Anderson J; Foster SA; Corrigan SM; Smith DM; Curkendall S
    J Diabetes Sci Technol; 2010 May; 4(3):547-57. PubMed ID: 20513319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dosing accuracy with a novel pen device (SoloSTAR) as performed by patients with diabetes in a clinical setting.
    Hermanns N; Kulzer B; Haak T
    Diabetes Technol Ther; 2008 Aug; 10(4):322-7. PubMed ID: 18715206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Evaluation of the practical use of the Becton-Dickinson (B-D) insulin pen injector].
    Sieradzki J; Koblik T
    Przegl Lek; 1994; 51(12):510-2. PubMed ID: 7746886
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Assessment for ease of use and preference of a new prefilled insulin pen (FlexTouch Degludec U100/U200) versus the SoloSTAR insulin pen by patients with diabetes and healthcare professionals.
    Pfützner A; Forst T; Niemeyer M; Bailey T
    Expert Opin Drug Deliv; 2014 Sep; 11(9):1381-9. PubMed ID: 24921223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A review of insulin pen devices.
    McCoy EK; Wright BM
    Postgrad Med; 2010 May; 122(3):81-8. PubMed ID: 20463417
    [TBL] [Abstract][Full Text] [Related]  

  • 15. New insulin analogues.
    Garg SK
    Diabetes Technol Ther; 2005 Oct; 7(5):813-7. PubMed ID: 16241890
    [No Abstract]   [Full Text] [Related]  

  • 16. Treatment of inpatient hyperglycemia beginning in the emergency department: a randomized trial using insulins aspart and detemir compared with usual care.
    Bernard JB; Munoz C; Harper J; Muriello M; Rico E; Baldwin D
    J Hosp Med; 2011 May; 6(5):279-84. PubMed ID: 21661100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using prandial insulin to achieve glycemic control in type 2 diabetes.
    Dailey GE
    J Fam Pract; 2007 Sep; 56(9):735-42. PubMed ID: 17764645
    [No Abstract]   [Full Text] [Related]  

  • 18. Dose accuracy of SoloSTAR and FlexPen as assessed in a clinical setting.
    Friedrichs A
    Diabetes Technol Ther; 2009 Sep; 11(9):609-13. PubMed ID: 19764841
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of once-daily glargine insulin with twice-daily NPH/regular insulin for control of hyperglycemia in inpatients after cardiovascular surgery.
    Yeldandi RR; Lurie A; Baldwin D
    Diabetes Technol Ther; 2006 Dec; 8(6):609-16. PubMed ID: 17109592
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patient acceptance and reliability of new Humulin/Humalog 3.0 ml prefilled insulin pen in ten Croatian diabetes centres.
    Sucic M; Galic E; Cabrijan T; Ivandic A; Petrusic A; Wyatt J; Mincheva N; Milicevic Z; Malone J
    Med Sci Monit; 2002 Mar; 8(3):PI21-6. PubMed ID: 11884952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.